Previous 10 | Next 10 |
TORONTO, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Torex Gold Resources Inc. (the “Company” or “Torex”) (TSX: TXG) announces the Company has received approval from Mexico’s Secretariat of Environment and Natural Resources (“SEMARNAT”) regarding an amendmen...
(All amounts expressed in U.S. Dollars unless otherwise stated) TORONTO, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Torex Gold Resources Inc. (the “Company” or “Torex”) (TSX: TXG) reports the Company’s financial and operational results for the three- and nine-month p...
OWKIN Integrates 10x Genomics Spatial Omics and Single-Cell Technologies to the MOSAIC Study PR Newswire PLEASANTON, Calif. and PARIS , Nov. 6, 2023 /PRNewswire/ -- OWKIN and 10x Genomics, Inc. (Nasdaq: TXG), announce they have entered into an agreement to ad...
2023-11-04 01:02:01 ET Summary 10x Genomics is a life science technology company with a clear mission and visionary leadership. 10x Genomics delivered a solid Q3 quarter with revenue reaching $154M, growing 17% YoY. The company has a huge growth opportunity in the genomics mar...
10x Genomics Inc. (TXG) is expected to report $-0.45 for Q3 2023
2023-11-02 23:27:08 ET 10x Genomics, Inc. (TXG) Q3 2023 Earnings Conference Call November 2, 2023 4:30 PM ET Company Participants Cassie Corneau - Director, Investor Relations and Strategic Finance Serge Saxonov - CEO and Co-Founder Justin McAnear - Chief Financi...
2023-11-02 16:26:09 ET More on 10x Genomics 10x Genomics: Recent Performance Amplifies My Bullish Conviction NanoString falls after prelim injunction in Germany in dispute with 10x Genomics Seeking Alpha’s Quant Rating on 10x Genomics For further detai...
10x Genomics Reports Third Quarter 2023 Financial Results PR Newswire PLEASANTON, Calif. , Nov. 2, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the third quarter ende...
2023-11-02 04:19:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron Discovery Fund was down 5.4% during Q3, which was 2.0% better than the Benchmark...
10x Genomics to Present at the Stephens 25th Annual Conference PR Newswire PLEASANTON, Calif. , Nov. 1, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that members of its management team will pa...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 06:00:09 ET Kyle Mikson from Canaccord Genuity issued a price target of $32.00 for TXG on 2024-07-23 05:09:00. The adjusted price target was set to $32.00. At the time of the announcement, TXG was trading at $18.11. The overall price target consensus is at $24...
10x Genomics to Report Second Quarter 2024 Financial Results on August 8, 2024 PR Newswire PLEASANTON, Calif. , July 12, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it will report fi...
A look at the top 10 most actives in the United States Kazia Therapeutics Limited (KZIA) rose 248.0% to $0.6682 on volume of 430,252,408 shares Maxeon Solar Technologies Ltd. (MAXN) fell 15.0% to $0.2108 on volume of 237,403,092 shares NVIDIA Corporation (NVDA) rose 2.7% to $134.91 on vol...